Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Gaylord Palms Resort & Convention Center

Mar 21, 2016 1:00 PM - Mar 23, 2016 4:30 PM

6000 West Osceola Parkway, Kissimmee, FL 34746

Medical Affairs and Scientific Communications 2016 Annual Forum

Cross-functional forum spotlights topics related to medical communication, medical science liaison, medical call center, and medical writing professionals.

Session 10: New Drugs of 2015 Review and Closing Remarks

Session Chair(s)

Craig  Klinger, RPh

Craig Klinger, RPh

Director - Global MSL Trainer, The Office of Medical Professional Development

Eli Lilly and Company, United States

Update your knowledge on drugs that have been approved or have been given new indications or line extensions by the FDA in 2015. A unique New Drug Comparison Rating (NDCR) system will be reviewed to allow the participant to understand the features of new drugs and explain their role among currently available therapies.

Learning Objective :
  • Identify the indications & routes of administration of the new therapeutic agents
  • Describe the important pharmacokinetic properties & the unique characteristics of the new drugs
  • Restate the most important adverse events & precautions of the new drugs
  • Compare the new drugs to the older therapeutic agents to which they are most similar in activity
  • Assess information regarding the new drugs that should be communicated to patients

Speaker(s)

Daniel A Hussar, PhD, MS

Speaker

Daniel A Hussar, PhD, MS

Philadelphia College of Pharmacy, University of the Sciences In Philadelphia, United States

Remington Professor of Pharmacy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.